查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1320232

癌症干细胞市场:各癌症形态，各用途，各国，各地区- 产业分析，市场规模，市场占有率，2023-2030年预测

Cancer Stem Cells Market with COVID-19 Impact Analysis, By Cancer Forms, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 359 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年癌症干细胞市场规模为 10.567 亿美元，2023 年至 2030 年复合年增长率将达到 9.1%

癌症干细胞市场 - 市场动态：

癌症疾病盛行率的增加和干细胞研究投资的增加预计将推动对癌症干细胞的需求。

癌症干细胞市场受到全球癌症发生率上升的显着影响。随着癌症仍然是全世界死亡的主要原因，使用癌症干细胞的研究和治疗变得越来越重要。对干细胞研究（特别是癌症干细胞）的资金和投资的增加正在加速新发现和创新疗法的创造。非营利基金会、营利公司和政府机构都为这一扩张做出了贡献。基因组学、分子生物学和免疫治疗领域的进步提高了对癌症干细胞及其在肿瘤发生和进展中的功能的理解。

製药公司资助临床试验和癌症干细胞研究，以开发专门针对癌症干细胞的新疗法。如果临床试验的结果是正面的，这将刺激市场扩张。临床试验对于确认潜在药物的安全性和有效性至关重要。

癌症干细胞市场 - 主要见解：

  • 由于对动物健康和营养的日益关注，癌症干细胞产业预计将大幅成长。
  • 从应用来看，标靶癌症干细胞区隔市场预计将在 2022 年展现最大的市场占有率。
  • 根据癌症形态，乳癌区隔市场在 2022 年处于领先地位。
  • 按地区划分，北美将在 2022 年实现销售领先。

癌症干细胞市场 - 区隔分析：

全球癌症干细胞市场根据癌症形态、应用、系统和区域进行区隔。

依癌症的形态，癌症分为七种：乳癌、血癌、脑瘤、肺癌、胰臟癌、膀胱癌和其他癌症。

市场依应用分为两类：标靶癌症干细胞和基于干细胞的癌症治疗。靶向癌症干细胞领域主导市场。小型干细胞的日益普及预计将支持市场成长。

癌症干细胞市场 - 地理洞察：

从地理上看，本报告涵盖北美、拉丁美洲、欧洲、亚太地区和中东非洲。这些地区根据其经营所在的国家进一步划分。

癌症干细胞市场 - 竞争格局：

医疗保健和基因工程的不断进步正在影响癌症干细胞市场。医疗机构（包括应用程式提供者）在多种因素上竞争，包括癌症治疗、声誉和可用性。企业进入市场和扩大市场占有率的主要方法和策略包括新产品发布、研发支出、分销网络开发和併购。以下介绍一些最近的趋势。

最近动态

2022 年 6 月，BlueRock Therapeutics 在德国引进了一个新的细胞治疗设施，以加强其在欧洲的临床能力。

调查的主要特征

  • 本研究报告提供了癌症干细胞市场的市场规模、复合年增长率 (CAGR%) 以及以 2022 年为基准年的估计和预测（2023-2030 年）。
  • 这份研究报告为客户提供了有关癌症干细胞市场最新趋势的见解。
  • 研究报告阐明了不同区隔市场/国家的潜在成长机会，并解释了癌症干细胞市场有吸引力的投资主张矩阵。
  • 确定癌症干细胞市场的新投资机会、现有公司面临的挑战以及永续成长因素。
  • 研究范围中详细讨论了癌症干细胞市场规模、预测、复合年增长率以及 COVID-19 对市场动态的影响，也涵盖了对 COVID-19 后癌症干细胞市场的详细见解。
  • 为了向本报告的使用者提供对癌症干细胞市场的全面了解，本报告也对癌症干细胞市场的竞争格局和关键创新者进行了分析。
  • 本报告包??含一份成长前景图分析，根据市场规模、成长率和吸引力对所有产业领域进行基准测试。
  • 本报告提供了主要市场参与者的详细公司概况，帮助您了解癌症干细胞市场中营运公司的财务状况和策略举措。
  • 此外，该报告还揭示了全球和区域市场主要参与者的重要收购和併购、联盟和合资企业、新产品发布、研发以及区域扩张。
  • 全球癌症干细胞市场报告主要针对该行业的各个利益相关者，例如供应商、投资者、新进业者、分销商和财务分析师。

目录

第1章 癌症干细胞市场概要

  • 调查范围

第2章 摘要整理

  • 市场明细
  • 竞争考察

第3章 癌症干细胞主要的市场趋势

  • 癌症干细胞推动市场要素
  • 癌症干细胞阻碍市场要素
  • 癌症干细胞市场机会
  • 癌症干细胞市场未来趋势

第4章 癌症干细胞产业调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法规结构的分析

第5章 癌症干细胞市场:COVID-19影响分析

  • 新型冠状病毒感染疾病前的影响分析
  • 新型冠状病毒感染疾病后的影响分析

第6章 癌症干细胞市场形势

  • 癌症干细胞市场占有率分析，2022年
  • 各主要製造商的明细资料
    • 确立的企业的分析
    • 新兴企业的分析

第7章 癌症干细胞市场- 各癌症形态

  • 概要
    • 各癌症形态市场区隔占有率分析
    • 胸
    • 血
    • 脑
    • 肺
    • 胰臟
    • 膀胱
    • 其他

第8章 癌症干细胞市场- 各用途

  • 概要
    • 各用途市场区隔占有率分析
    • 标的癌症性干细胞
    • 干细胞为基础癌症治疗

第9章 癌症干细胞市场-各地区

  • 简介
  • 北美
    • 概要
    • 癌症干细胞的北美的主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概要
    • 癌症干细胞的欧洲的主要製造商
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区(APAC)
    • 概要
    • 亚太地区的癌症干细胞的主要製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 其他
  • 南美
    • 概要
    • 癌症干细胞南美的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概要
    • 中东及非洲的癌症干细胞的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第10章 主要供应商分析- 癌症干细胞产业

  • 竞争仪表板
  • 企业简介
    • Thermo Fisher Scientific, Inc.
    • AbbVie, Inc.
    • Merck KGaA
    • Bionomics
    • Lonza
    • Stemline Therapeutics, Inc.
    • Miltenyi Biotec
    • PromoCell GmbH
    • MacroGenics, Inc
    • OncoMed Pharmaceuticals, Inc.
    • Irvine Scientific
    • STEMCELL Technologies Inc.
    • BlueRock Therapeutics
    • Sino Biological Inc.
    • Biotime Inc.

第11章 分析师的全方位展望

Product Code: ANV1543

REPORT HIGHLIGHT

Cancer Stem Cells Market size was valued at USD 1,056.7 Million in 2022, expanding at a CAGR of 9.1% from 2023 to 2030.

A subgroup of cells having stem cell-like characteristics that are present in tumors are known as cancer stem cells. They have the same capacity for self-renewal and cell cancer forms differentiation as regular stem cells. However, cancer stem cells are tumorigenic, meaning they can give rise to new cancer cells and aid in the spread of disease, in contrast to normal stem cells.

Cancer Stem Cells Market- Market Dynamics:

Growing prevalence of cancer diseases and rising investment in stem cell research is expected to propel the cancer stem cells demand.

The market for cancer stem cells has been significantly influenced by the rising incidence of cancer across the world. Research and treatments involving cancer stem cells are becoming more important as cancer continues to be the leading cause of death worldwide. The rate of new discoveries and the creation of innovative therapies has accelerated due to increased financing and investment in stem cell research, especially cancer stem cells. Nonprofit foundations, for-profit businesses, and government agencies have all contributed to this expansion. Understanding cancer stem cells and their function in tumor initiation and progression has improved because of developments in the fields of genomics, molecular biology, and immunotherapy.

Pharmaceutical corporations are funding clinical trials and research into cancer stem cells to create novel treatments that specifically target these cells. Positive trial outcomes can spur market expansion. Clinical studies are crucial for confirming the security and effectiveness of prospective medicines.

Cancer Stem Cells Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Stem Cells market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2023-2030)
  • The Cancer Stem Cells industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Application, targeted cancerous stem cells segment was predicted to show maximum market share in the year 2022.
  • Based on Cancer Forms, segmentation, breast cancer segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Cancer Stem Cells Market- Segmentation Analysis:

The Global Cancer Stem Cells Market is segmented on the basis of Cancer Forms, Application, System, and Region.

The market is divided into seven categories based on Cancer Forms: breast, blood, brain, lung, pancreatic, bladder, and others. The rocket launchers segment dominates the market. Increasing demand rocket launching system is contributing to market growth.

The market is divided into two categories based on Application: targeted cancerous stem cells, and stem-cell based cancer therapy. The targeted cancerous stem cells segment dominates the market. Growing prevalence of small stem cells is expected to boost the market growth.

Cancer Stem Cells Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Cancer Stem Cells Market- Competitive Landscape:

Owing to the increasing advancement in healthcare and genetic engineering, which influence the Cancer Stem Cells market. Healthcare facilities including application providers compete on various factors, such as cancer therapy, reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In June 2022, BlueRock Therapeutics has introduced new cell treatment site in Germany to enhance its clinical capabilities in Europe.

Key features of the study:

  • This proposed research study on Cancer Stem Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Stem Cells market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Stem Cells market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Stem Cells market
  • Impact of COVID-19 on Cancer Stem Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Stem Cells market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Stem Cells market, we have also included competitive landscape and key innovator analysis for the Cancer Stem Cells market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Cancer Stem Cells market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Stem Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER STEM CELLS MARKET KEY PLAYERS

  • Thermo Fisher Scientific, Inc.
  • AbbVie, Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics, Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics, Inc
  • OncoMed Pharmaceuticals, Inc.
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • BlueRock Therapeutics
  • Sino Biological Inc.
  • Biotime Inc.

GLOBAL CANCER STEM CELLS MARKET, BY CANCER FORMS

  • Breast
  • Blood
  • Brain
  • Lung
  • Pancreatic
  • Bladder
  • Others

GLOBAL CANCER STEM CELLS MARKET, BY APPLICATION

  • Targeted Cancerous Stem Cells
  • Stem-cell based Cancer Therapy

GLOBAL CANCER STEM CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Stem Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Stem Cells Market Snippet by Cancer Forms
    • 2.1.2. Cancer Stem Cells Market Snippet by Application
    • 2.1.3. Cancer Stem Cells Market Snippet by Country
    • 2.1.4. Cancer Stem Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Stem Cells Key Market Trends

  • 3.1. Cancer Stem Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Stem Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Stem Cells Market Opportunities
  • 3.4. Cancer Stem Cells Market Future Trends

4. Cancer Stem Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Stem Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Stem Cells Market Landscape

  • 6.1. Cancer Stem Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Stem Cells Market - By Cancer Forms

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Cancer Forms, 2022 & 2030 (%)
    • 7.1.2. Breast
    • 7.1.3. Blood
    • 7.1.4. Brain
    • 7.1.5. Lung
    • 7.1.6. Pancreatic
    • 7.1.7. Bladder
    • 7.1.8. Others

8. Cancer Stem Cells Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Targeted Cancerous Stem Cells
    • 8.1.3. Stem-cell based Cancer Therapy

9. Cancer Stem Cells Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Cancer Stem Cells Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.6.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.7.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Cancer Stem Cells Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.11.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.14.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Cancer Stem Cells Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. China Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. South Korea Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Australia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Australia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Indonesia
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Indonesia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Philippines
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Philippines Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.15. Rest of APAC
      • 9.4.15.1. Overview
      • 9.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.15.3. Rest of APAC Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Cancer Stem Cells Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Brazil Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Mexico Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Argentina Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Colombia
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Colombia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.11. Rest of LATAM
      • 9.5.11.1. Overview
      • 9.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.11.3. Rest of LATAM Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Cancer Stem Cells Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. Saudi Arabia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. United Arab Emirates Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Israel
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Israel Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Turkey
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Turkey Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Algeria
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Algeria Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Egypt
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Egypt Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.13. Rest of MEA
      • 9.6.13.1. Overview
      • 9.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.13.3. Rest of MEA Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Cancer Stem Cells Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific, Inc.
    • 10.2.2. AbbVie, Inc.
    • 10.2.3. Merck KGaA
    • 10.2.4. Bionomics
    • 10.2.5. Lonza
    • 10.2.6. Stemline Therapeutics, Inc.
    • 10.2.7. Miltenyi Biotec
    • 10.2.8. PromoCell GmbH
    • 10.2.9. MacroGenics, Inc
    • 10.2.10. OncoMed Pharmaceuticals, Inc.
    • 10.2.11. Irvine Scientific
    • 10.2.12. STEMCELL Technologies Inc.
    • 10.2.13. BlueRock Therapeutics
    • 10.2.14. Sino Biological Inc.
    • 10.2.15. Biotime Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Stem Cells Market: Cancer Forms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Forms
  • TABLE Global Cancer Stem Cells Market, by Cancer Forms 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Cancer Stem Cells Market, by Product 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Regional snapshot (2022)
  • TABLE Cancer Stem Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Stem Cells Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Stem Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Stem Cells Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Cancer Forms segment market share analysis, 2022 & 2030
  • FIGURE Cancer Forms segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Europe Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Latin America Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Stem Cells Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Germany Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE India Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Brazil Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)